Medistep HealthcareNSE:MEDISTEP -5.24%19 Net Margin % is 8.35% as of Mar. 2025, which is 43% above its 10-year median of 5.84. GuruFocus rates NSE:MEDISTEP with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 117 Medical Distribution companies, Medistep Healthcare ranks better than 88.89% on this metric.
The historical rank and industry rank for Medistep Healthcare's Net Margin % or its related term are showing as below:
NSE:MEDISTEP'
s Net Margin % Range Over the Past 10 Years
Min: 2.49 Med: 5.84 Max: 8.52
Current: 8.35
NSE:MEDISTEP's Net Margin % is ranked better than 88.89% of 117
companies
in the Medical Distribution industry
Industry Median: 1.5
vs NSE:MEDISTEP: 8.35
Medistep Healthcare (NSE:MEDISTEP) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Medistep Healthcare Net Margin % Related Terms
Medistep Healthcare Net Margin % Historical Data
* Premium members only.
The historical data trend for Medistep Healthcare's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistep Healthcare Net Margin % Chart
Medistep Healthcare Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Net Margin %
2.49
3.33
8.52
8.35
Medistep Healthcare Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Net Margin %
2.49
3.33
8.52
8.35
NSE:MEDISTEP vs MCK, COR, CAH: Net Margin % Comparison
For the Medical Distribution subindustry, Medistep Healthcare's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medistep Healthcare Net Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medistep Healthcare's Net Margin % distribution charts can be found below:
* The bar in red indicates where Medistep Healthcare's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medistep Healthcare (NSE:MEDISTEP) has a Net Margin % of 8.35% as of Mar. 2025. Net margin is the ratio of total net income to net sales. View historical data on Medistep Healthcare and its competitors. This is 43% above median its historical median of 5.84. Over the past decade, Medistep Healthcare's Net Margin % has ranged from 2.49 to 8.52. According to the industry distribution chart, Medistep Healthcare ranks #13 out of 117 companies in the Medical Distribution industry, placing it in the top 11.1%.
Is Medistep Healthcare's Net Margin % too high?
Medistep Healthcare's current Net Margin % of 8.35% is 43% above median its 10-year median of 5.84. Over the past 10 years, this metric has ranged from a low of 2.49 to a high of 8.52. The Medical Distribution industry median Net Margin % is 1.50. Medistep Healthcare's value of 8.35% is 456.7% above this industry median. Based on the distribution chart, Medistep Healthcare ranks #13 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medistep Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Medistep Healthcare's Net Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Medistep Healthcare ranks #13 out of 117 companies for Net Margin %. This places Medistep Healthcare in the top 11% of its industry — outperforming the majority of peers. The industry median Net Margin % is 1.50. Medistep Healthcare's value of 8.35% is 456.7% above this benchmark. Historically, Medistep Healthcare's own Net Margin % has ranged from 2.49 to 8.52 over the past decade. While the company's 10-year median is 5.84 vs. the industry median of 1.50, Medistep Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Distribution company?
The median Net Margin % among Medical Distribution companies is 1.50, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medistep Healthcare's current Net Margin % of 8.35% is 456.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Medistep Healthcare and its competitors. For the Medical Distribution industry, the median Net Margin % is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medistep Healthcare's current Net Margin % is 8.35%, which is 43% above median its own 10-year median of 5.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medistep Healthcare stock overvalued right now?
Medistep Healthcare (NSE:MEDISTEP) has a current Net Margin % of 8.35%. The current Net Margin % is 8.35%, which is 43% above median its 10-year median of 5.84 and 456.7% above the Medical Distribution industry median of 1.50. Medistep Healthcare's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Medistep Healthcare (NSE:MEDISTEP), the current Net Margin % is 8.35% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medistep Healthcare Ltd operates in the pharmaceutical and healthcare product sectors. Its business includes manufacturing intimate care and hygiene products such as sanitary pads, as well as nutraceutical products like energy powders. The company also trades a variety of pharmaceutical, surgical, and medical equipment products. Medistep Healthcare's operations focus mainly on the western region of India, particularly in Gujarat. Its Core business activity is divided into the following categories: a) Trading of Pharmaceutical & Surgical products, b) Trading & Manufacturing of Nutraceuticals and Intimate care & hygiene products. The company generates the majority of its revenue from Trading and distribution.
19GF Score
Get the complete analysis for NSE:MEDISTEP
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MEDISTEP has been successfully added to your 